Larvol Delta - BlueSphere-Bio-To-Partner-with-NMDP-BioTherapies-for-the-Companys-FirstInHuman-TCRbased-Product-Candidate-in-Combination-with-Allogeneic-Hematopoietic-Cell-Transplantation-Trial

BSB-1001 - BlueSphere Bio

https://www.globenewswire.com/news-release/2024/06/25/2903924/0/en/BlueSphere-Bio-To-Partner-with-NMDP-BioTherapies-for-the-Company-s-First-In-Human-TCR-based-Product-Candidate-in-Combination-with-Allogeneic-Hematopoietic-Cell-Transplantation-Tria.html

Jun 25, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next